Article Details
Retrieved on: 2024-03-12 20:52:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the challenges faced by the FDA in regulating SaMD, particularly AI/ML-based medical software. Despite advancements in digital health, the FDA's cybersecurity and regulatory framework under the Federal Food, Drug, and Cosmetic Act struggles to keep pace with technological innovation.
Article found on: www.mintz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here